534. TGF-β as a Modifier of Response to Adoptive Cell Therapy for Melanoma: Enhanced Tumor Treatment in Animal Models and a Highly Significant Correlation Between Clinical Response and TGF-β Genotypes

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36338-9
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

TGF-β Antagonists: Why Suppress a Tumor Suppressor?

Journal of Clinical Investigation
Medicine
2002English

Mechanisms of Coronary Angiogenesis in Response to Stretch: Role of VEGF and TGF-β

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2001English

Critical Interactions Between TGF-β Signaling/Elf, and E-Cadherin/Β-Catenin Mediated Tumor Suppression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-Β Treatment

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2016English

TGF-β: A Master of All T Cell Trades

Cell
BiochemistryGeneticsMolecular Biology
2008English

TGF-β2 Dictates Disseminated Tumour Cell Fate in Target Organs Through TGF-β-RIII and P38α/Β Signalling

Nature Cell Biology
Cell Biology
2013English

TGF-β Signaling

WormBook
2005English

TGF-β Family Signaling in Tumor Suppression and Cancer Progression

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2017English

Preclinical Rationale for TGF-β Inhibition as a Therapeutic Target for the Treatment of Myelofibrosis

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy